Delivery Order SPE2DB22D2211-SPE2DB25FSDGL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Calquence 100 mg tablets (60-unit quantity) under a firm fixed-price contract with a ceiling value of $5,593.77. This non-set-aside delivery order is scheduled for completion by September 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Calquence 100 mg tablets (60-count package) valued at $11,187.56. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under the company's existing indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a contract ceiling value of $5,593.77 and an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation, indicating the vendor's capability to meet federal procurement standards through open competition. The contract is performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract valued at $5,593.77. This non-competitive delivery order, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a contract ceiling value of $5,593.77. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $11,187.56. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $5,593.77. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and was competitively awarded without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $16,781.31. This firm fixed-price delivery order, which is not set-aside and represents a competitive award, is scheduled for ultimate completion by September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency awarded a $5,593.77 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Calquence 100 mg tablets (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,593.77 on August 1, 2025, for the supply of Calquence 100 mg tablets (60 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 22, 2025, and performance to be fulfilled at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's broader relationship with DLA, leveraging the company's...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDGLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Calquence 100 mg tablets in quantities of 60 units, with a ceiling value of $5,593.77. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and was awarded through open competition without set-aside provisions. The order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, demonstrates substantial capability in fulfilling the Defense Logistics Agency's pharmaceutical supply requirements through its established relationship with DLA and history of competitively awarded contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 8/20/25 |